These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 23405984)
1. Solution structure and in silico binding of a cyclic peptide with hepatitis B surface antigen. Muhamad A; Ho KL; Rahman MB; Uhrín D; Tan WS Chem Biol Drug Des; 2013 Jun; 81(6):784-94. PubMed ID: 23405984 [TBL] [Abstract][Full Text] [Related]
2. A phage-displayed cyclic peptide that interacts tightly with the immunodominant region of hepatitis B surface antigen. Tan WS; Tan GH; Yusoff K; Seow HF J Clin Virol; 2005 Sep; 34(1):35-41. PubMed ID: 16087122 [TBL] [Abstract][Full Text] [Related]
3. Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library. Ho KL; Yusoff K; Seow HF; Tan WS J Med Virol; 2003 Jan; 69(1):27-32. PubMed ID: 12436474 [TBL] [Abstract][Full Text] [Related]
4. Conformational and ion binding properties of a cyclic octapeptide, cyclo (Ala-Leu-Pro-Gly)2. Jois DS; Easwaran KR; Bednarek M; Blout ER Biopolymers; 1992 Aug; 32(8):993-1001. PubMed ID: 1420982 [TBL] [Abstract][Full Text] [Related]
5. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution. Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668 [TBL] [Abstract][Full Text] [Related]
6. Solution structure of an N-capping peptide from the N-terminal leucine-repeat region of hepatitis delta antigen. Lou YC; Lin IJ; Pai MT; Cheng JW Arch Biochem Biophys; 2000 May; 377(2):219-27. PubMed ID: 10845697 [TBL] [Abstract][Full Text] [Related]
7. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val). Liu ZP; Gierasch LM Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655 [TBL] [Abstract][Full Text] [Related]
8. Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries. D'Mello F; Partidos CD; Steward MW; Howard CR Virology; 1997 Oct; 237(2):319-26. PubMed ID: 9356343 [TBL] [Abstract][Full Text] [Related]
9. Computational and experimental investigations into the conformations of cyclic tetra-α/β-peptides. Oakley MT; Oheix E; Peacock AF; Johnston RL J Phys Chem B; 2013 Jul; 117(27):8122-34. PubMed ID: 23758504 [TBL] [Abstract][Full Text] [Related]
10. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin. Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578 [TBL] [Abstract][Full Text] [Related]
11. Highly selective cyclic peptide ligands for NeutrAvidin and avidin identified by phage display. Meyer SC; Gaj T; Ghosh I Chem Biol Drug Des; 2006 Jul; 68(1):3-10. PubMed ID: 16923020 [TBL] [Abstract][Full Text] [Related]
12. Structural recognition of an ICAM-1 peptide by its receptor on the surface of T cells: conformational studies of cyclo (1, 12)-Pen-Pro-Arg-Gly-Gly-Ser-Val-Leu-Val-Thr-Gly-Cys-OH. Gürsoy RN; Jois DS; Siahaan TJ J Pept Res; 1999 Apr; 53(4):422-31. PubMed ID: 10406220 [TBL] [Abstract][Full Text] [Related]
13. Structure-antigenicity relationship of peptides from the pre-S2 region of the hepatitis B virus surface antigen. Lee MK; Kim KL; Hahm KS; Yang KH Biochem Mol Biol Int; 1994 Aug; 34(1):159-68. PubMed ID: 7531533 [TBL] [Abstract][Full Text] [Related]
14. Adsorption behavior of linear and cyclic genetically engineered platinum binding peptides. Seker UO; Wilson B; Dincer S; Kim IW; Oren EE; Evans JS; Tamerler C; Sarikaya M Langmuir; 2007 Jul; 23(15):7895-900. PubMed ID: 17579466 [TBL] [Abstract][Full Text] [Related]
15. A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements. De Luca S; Ragone R; Bracco C; Digilio G; Aloj L; Tesauro D; Saviano M; Pedone C; Morelli G Chembiochem; 2003 Nov; 4(11):1176-87. PubMed ID: 14613109 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, DNA binding, and sequence specificity of DNA alkylation by some novel cyclic peptide-chlorambucil conjugates. Sheh L; Chang HW; Ong CW; Chen SL; Bailly C; Linssen RC; Waring MJ Anticancer Drug Des; 1995 Jul; 10(5):373-88. PubMed ID: 7639928 [TBL] [Abstract][Full Text] [Related]
17. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7. Tan GH; Yusoff K; Seow HF; Tan WS J Med Virol; 2005 Dec; 77(4):475-80. PubMed ID: 16254965 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a C(K/R)TC motif as a common epitope present in all subtypes of hepatitis B surface antigen. Qiu X; Schroeder P; Bridon D J Immunol; 1996 May; 156(9):3350-6. PubMed ID: 8617960 [TBL] [Abstract][Full Text] [Related]
19. Secondary structure of a dynamic type I'beta-hairpin peptide. Stotz CE; Borchardt RT; Middaugh CR; Siahaan TJ; Vander Velde D; Topp EM J Pept Res; 2004 Apr; 63(4):371-82. PubMed ID: 15102055 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain. Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]